Cargando…
The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
BACKGROUND: Sugammadex is a novel neuromuscular reversal agent, but its associated hypersensitivity reaction and high cost have been obstacles to its widespread use. In the interest of reducing the necessary dosage of sugammadex, the reversal time of the combined use of sugammadex and neostigmine fr...
Autores principales: | Cheong, Soon Ho, Ki, Seunghee, Lee, Jiyong, Lee, Jeong Han, Kim, Myoung-Hun, Hur, Dongki, Cho, Kwangrae, Lim, Se Hun, Lee, Kun Moo, Kim, Young-Jae, Lee, Wonjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Anesthesiologists
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667139/ https://www.ncbi.nlm.nih.gov/pubmed/26634077 http://dx.doi.org/10.4097/kjae.2015.68.6.547 |
Ejemplares similares
-
Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013) -
Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019) -
Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
por: Ren, Maodong, et al.
Publicado: (2020) -
An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
por: Paredes, Stephania, et al.
Publicado: (2023) -
Effects of Sugammadex and Neostigmine on Renal Biomarkers
por: Isik, Yasemin, et al.
Publicado: (2016)